| Alternative name 1: |
Clone: 6G8, Mab anti-, CITED1 |
| Alternative name 2: |
Clone: 6G8, Mab antibody-, CITED1 |
| Alternative name 3: |
Clone: 6G8, Mab antibody-, CITED1 |
| Alternative name 4: |
anti-CITED1 Clone: 6G8 |
| Alternative name 5: |
CITED1 Clone: 6G8 |
| Clonality: |
Monoclonal Antibody |
| Description: |
Amongst the advantages of the monoclonal antibodies are: the fact that while the hybridoma takes a bit longer to be produced, If used correctly and according the protocol, in comparison to the polyclonal antibodies monoclonal antibodies are highly specific to a given epitope and can be used in applications where specific targeting is required, once the line is ready there is virtually an endless supply of these antibodie throughout time with little to no variations in recognition sites of the antigen in different batches, this antibody will provide excellent and reproducible results with guaranteed success for the tested and confirmed applications, This is a monoclonal antibody which is greatly purified and with high binding affinity for the antigen that it is risen against |
| Storage and handling: |
Antibodies in a liquid form can be shipped and stored for a short period of time at +4 degrees Celsius, antibodies that are lyophilized can be transported at ambient temperature and stored for short terms at +4 degrees Celsius, for long term storage (up to one year) 25-50% glycerol or ethylene glycol should be added and then the container has to be stored at -20°, for longer periods - at -20 , C, Generally |
| Advisory: |
For antibodies in a liquid form or reconstituted lyophilized antibodies small amounts of the soultion could be captured on the cap or the walls of the container, Right before use you could briefly centrifuge the vial to collect all of the solution on the bottom, To keep the quality and the affinity of the antibody cycles of freezing and thawing should be avoided |
| About: |
Each murine monoclonal anibody has his own affinity specific for the clone, Mouse monoclonal antibodies are purified protein A or G and can be conjugated to FITC for flow cytometry or FACS and can be of different isotypes, Monoclonals of this antigen are available in different clones |
| Test: |
A/J, BALB/c, Mouse are mature after 40 days for females and 55 days for males, SCID while the CD-1 is outbred as strain, The female mice are pregnant only 20 days and can give birth to 10 litters of 6-8 mice a year, Transgenic, congenic and inbread strains are known for C57BL/6, knock-out, Mouse , mice from the Mus musculus species are used for production of mouse monoclonal antibodies or mabs and as research model for humans in your lab, or |
| Latin name: |
Mus musculus |
| French translation: |
anticorps |
| Gene target: |
Monoclonal 6G8, CITED1 |
| Short name: |
Mouse Monoclonal antibody- Clone: 6G8, CITED1 |
| Technique: |
Monoclonals or monoclonal antibodies, mouses, Mouse |
| Species: |
Mouses, Mouse |
| Alternative name: |
1, Mouse monoclonal (Antibody to)-, clonality: 6G8, including L-gutamic acid/L-aspartic acid-rich carboxy-terminal domain, Cbp/p300-interacting transactivator |
| Alternative technique: |
murine |
| Alternative to gene target: |
1, CITED1 and IDBG-635694 and ENSBTAG00000045925 and 282182, CITED1 and IDBG-76674 and ENSG00000125931 and 4435, Cited1 and IDBG-164976 and ENSMUSG00000051159 and 12705, DNA-templated and biological process this GO :0006355 and regulation of transcription, DNA-templated and biological process this GO :0006357 and regulation of transcription from RNA polymerase II promoter and biological process this GO :0006913 and nucleocytoplasmic transport and biological process this GO :0006915 and apoptotic process and biological process this GO :0007179 and transforming growth factor beta receptor signaling pathway and biological process this GO :0007420 and brain development and biological process this GO :0008022 and protein C-terminus binding and molecular function this GO :0008283 and cell proliferation and biological process this GO :0010628 and positive regulation of gene expression and biological process this GO :0030178 and negative regulation of Wnt signaling pathway and biological process this GO :0030318 and melanocyte differentiation and biological process this GO :0030511 and positive regulation of transforming growth factor beta receptor signaling pathway and biological process this GO :0032496 and response to lipopolysaccharide and biological process this GO :0032868 and response to insulin and biological process this GO :0034097 and response to cytokine and biological process this GO :0034341 and response to interferon-gamma and biological process this GO :0042438 and melanin biosynthetic process and biological process this GO :0042803 and protein homodimerization activity and molecular function this GO :0043473 and pigmentation and biological process this GO :0043524 and negative regulation of neuron apoptotic process and biological process this GO :0043627 and response to estrogen and biological process this GO :0044212 and transcription regulatory region DNA binding and molecular function this GO :0045668 and negative regulation of osteoblast differentiation and biological process this GO :0045892 and negative regulation of transcription, DNA-templated and biological process this GO :0045893 and positive regulation of transcription, DNA-templated and biological process this GO :0050693 and LBD domain binding and molecular function this GO :0051591 and response to cAMP and biological process this GO :0060231 and mesenchymal to epithelial transition and biological process this GO :0060395 and SMAD protein signal transduction and biological process this GO :0060711 and labyrinthine layer development and biological process this GO :0060712 and spongiotrophoblast layer development and biological process this GO :0070410 and co-SMAD binding and molecular function this GO :0070555 and response to interleukin-1 and biological process this GO :0070669 and response to interleukin-2 and biological process this GO :0070670 and response to interleukin-4 and biological process this GO :0070741 and response to interleukin-6 and biological process this GO :0071104 and response to interleukin-9 and biological process this GO :0071105 and response to interleukin-11 and biological process this GO :0071107 and response to parathyroid hormone and biological process this GO :0071559 and response to transforming growth factor beta and biological process, MSG1, co-SMAD binding, nuclei, this GO :0000578 and embryonic axis specification and biological process this GO :0001570 and vasculogenesis and biological process this GO :0001656 and metanephros development and biological process this GO :0001658 and branching involved in ureteric bud morphogenesis and biological process this GO :0001890 and placenta development and biological process this GO :0003340 and negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis and biological process this GO :0003682 and chromatin binding and molecular function this GO :0003700 and sequence-specific DNA binding transcription factor activity and molecular function this GO :0003713 and transcription coactivator activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005829 and cytosol and cellular component this GO :0006351 and transcription, this GO :0003682 : chromatin binding, this GO :0003682 : chromatin binding and also this GO :0003700 : sequence-specific DNA binding transcription factor activity and also this GO :0003713 : transcription coactivator activity and also this GO :0005515 : protein binding and also this GO :0008022 : protein C-terminus binding and also this GO :0042803 : protein homodimerization activity and also this GO :0044212 : transcription regulatory region DNA binding and also this GO :0050693 : LBD domain binding and also this GO :0070410 : co-SMAD binding, this GO :0003700 : sequence-specific DNA binding transcription factor activity, this GO :0003713 : transcription coactivator activity, this GO :0005515 : protein binding, this GO :0008022 : protein C-terminus binding, this GO :0042803 : protein homodimerization activity, this GO :0044212 : transcription regulatory region DNA binding, this GO :0050693 : LBD domain binding, this GO :0070410 : co-SMAD binding, with Glu/Asp-rich carboxy-terminal domain, Cbp/p300-interacting transactivator |
| Identity: |
1986 |
| Gene: |
CITED1 |
More about : CITED1 |
| Long gene name: |
Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1 |
| Synonyms gene: |
MSG1 |
| Synonyms gene name: |
1 , Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain |
| Locus: |
Xq13, 1 |
| Discovery year: |
1998-03-27 |
| GenBank acession: |
U65092 |
| Entrez gene record: |
4435 |
| Pubmed identfication: |
8901575 9721210 |
| RefSeq identity: |
NM_004143 |
| Havana BLAST/BLAT: |
OTTHUMG00000021812 |
| Locus Specific Databases: |
Mental Retardation database |